Omeros (OMER) Prepaid Assets (2010 - 2026)
Omeros recorded quarterly Prepaid Assets of $7.3 million in Q1 2026, down 3.27% quarter-over-quarter from $7.6 million in Q4 2025, and down 1.61% year-over-year from $7.5 million in Q1 2025.
Omeros' Prepaid Assets history runs 17 years deep, the most recent figure standing at $7.3 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 1.61% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $7.3 million (down 1.61% YoY), while the FY2025 annual figure was $7.6 million, up 5.99% from the prior year.
- Prepaid Assets came in at $7.3 million for Q1 2026 at Omeros, down from $7.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $13.5 million in Q1 2024 to a low of $3.8 million in Q3 2025.
- A 5-year average of $7.3 million and a median of $7.0 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 100.7% in 2024 and plunged 44.54% in 2025, its largest moves.
- Omeros' Prepaid Assets stood at $6.3 million in 2022, then jumped by 36.21% to $8.6 million in 2023, then slipped by 16.49% to $7.2 million in 2024, then advanced by 5.99% to $7.6 million in 2025, then decreased by 3.27% to $7.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $7.3 million, $7.6 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.35 Mn |
| Dec 31, 2025 | 7.60 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 6.41 Mn |
| Mar 31, 2025 | 7.47 Mn |
| Dec 31, 2024 | 7.17 Mn |
| Sep 30, 2024 | 6.13 Mn |
| Jun 30, 2024 | 6.27 Mn |
| Mar 31, 2024 | 13.46 Mn |
| Dec 31, 2023 | 8.58 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 6.71 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 5.98 Mn |
| Jun 30, 2022 | 11.89 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 8.22 Mn |
| Sep 30, 2021 | 6.37 Mn |
| Jun 30, 2021 | 5.93 Mn |
| Mar 31, 2021 | 5.98 Mn |
| Dec 31, 2020 | 10.46 Mn |
| Sep 30, 2020 | 3.54 Mn |
| Jun 30, 2020 | 5.17 Mn |
| Mar 31, 2020 | 6.30 Mn |
| Dec 31, 2019 | 6.63 Mn |
| Sep 30, 2019 | 5.35 Mn |
| Jun 30, 2019 | 4.40 Mn |
| Mar 31, 2019 | 4.20 Mn |
| Dec 31, 2018 | 6.46 Mn |
| Sep 30, 2018 | 8.33 Mn |
| Jun 30, 2018 | 6.34 Mn |
| Mar 31, 2018 | 5.44 Mn |
| Dec 31, 2017 | 7.04 Mn |
| Sep 30, 2017 | 5.69 Mn |
| Jun 30, 2017 | 3.45 Mn |
| Mar 31, 2017 | 3.26 Mn |
| Dec 31, 2016 | 1.77 Mn |
| Sep 30, 2016 | 1.36 Mn |
| Jun 30, 2016 | 2.28 Mn |
| Mar 31, 2016 | 2.46 Mn |
| Dec 31, 2015 | 1.89 Mn |
| Sep 30, 2015 | 99,000.00 |
| Jun 30, 2015 | 108,000.00 |
| Mar 31, 2015 | 1.78 Mn |
| Dec 31, 2014 | 1.20 Mn |
| Sep 30, 2014 | 148,000.00 |
| Jun 30, 2014 | 146,000.00 |
| Mar 31, 2014 | 143,000.00 |
| Dec 31, 2013 | 86,000.00 |
| Sep 30, 2013 | 391,000.00 |
| Jun 30, 2013 | 494,000.00 |
| Mar 31, 2013 | 494,000.00 |
| Dec 31, 2012 | 416,000.00 |
| Sep 30, 2012 | 341,000.00 |
| Jun 30, 2012 | 485,000.00 |
| Mar 31, 2012 | 438,000.00 |
| Dec 31, 2011 | 502,000.00 |
| Sep 30, 2011 | 210,000.00 |
| Jun 30, 2011 | 333,000.00 |
| Dec 31, 2010 | 282,000.00 |